HIV, a Typical Retrovirus Life Cycle
HIV, or human immunodeficiency virus, is a retrovirus that infects and destroys the immune system's CD4+ T cells, leading to acquired immunodeficiency syndrome (AIDS). But how does this tiny virus manage to invade cells and cause so much damage? Here's an overview.
Lenacapavir: Market Analysis of the First-in-Class Capsid Inhibitor
In August 2022, Gilead announced that the European Commission (EC) has granted marketing authorization for Sunlenca (Lenacapavir), an innovative treatment for adults with multi-drug resistant HIV infection. The treatment works in combination with other antiretroviral(s) when it isn't
A Breif Drug Development Analysis of Antiretrovirals
Antiretroviral drugs have evolved significantly over time, with new drugs continuously being developed. The analysis below provides some insights into the development timeline, the focus on drug classes, and the use of drugs in combination formulations.Evolution of Drug ClassesThe following timeline